Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
Thu, 05/23/19 - 10:45 pm
Tags:
depression, ketamine, esketamine, Spravato, JNJ, Janssen
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
Wed, 04/17/19 - 09:45 am
Tags:
JNJ, Janssen, Stelara, drug pricing
J&J's Balversa gets accelerated approval for bladder cancer
BioCentury
Fri, 04/12/19 - 11:40 pm
Tags:
JNJ, Janssen, Balversa, bladder cancer, FDA
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
Tags:
ViiV Healthcare, Dolutegravir, rilpivirine, JNJ, Janssen, HIV
Janssen laying off 4 dozen employees as California plant heads toward closure
Fierce Pharma
Tue, 04/2/19 - 11:26 pm
Tags:
JNJ, Janssen, California, layoffs, drug manufacturing
Janssen, Scripps discover small molecule for flu
BioCentury
Fri, 03/8/19 - 04:12 pm
Tags:
JNJ, Janssen, Scripps Research Institute, Flu, influenza, small molecule drugs
Monthly shots control HIV as well as daily pills in two big studies
Stat
Thu, 03/7/19 - 09:21 pm
Tags:
HIV, AIDS, JNJ, Janssen, ViiV Healthcare, cabotegravir, Edurant
FDA approves Janssen's fast-acting depression therapy esketamine
BioCentury
Wed, 03/6/19 - 12:43 am
Tags:
FDA, Spravato, esketamine, Janssen, JNJ, major depression
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Mon, 03/4/19 - 12:08 pm
Tags:
Novartis, Janssen, JNJ, psoriasis, false advertising, Tremfya
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
Yahoo/Benzinga
Sun, 03/3/19 - 07:09 pm
Tags:
IPOs, biotech, JNJ, Janssen, esketamine, Shockwave Medical, earnings, Sensen Bio, MyoKardia
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
Tags:
JNJ, Janssen, Tremfya, psoriasis, Novartis, Cosentyx, Eli Lilly, Taltz
MorphoSys Settles Patent Lawsuit with Janssen and Genmab
CP Wire
Fri, 02/1/19 - 09:44 am
Tags:
MorphoSys, Janssen, Genmab, daratumumab, patents
Fri, 02/1/19 - 09:25 am
Tags:
MorphoSys, Janssen, Genmab, patent lawsuits, patents, Darazalex
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Tags:
Imbruvica, Janssen, AbbVie, Roche, Gazyva, chronic lymphocytic leukemia, small lymphocytic lymphoma, FDA
MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab
CP Wire
Mon, 01/28/19 - 11:02 am
Tags:
MorphoSys, Janssen, Genmab, patents
Mon, 01/28/19 - 10:10 am
Tags:
MorphoSys, Janssen, Genmab
Apple and Johnson & Johnson collaborating on heart research project
Marketwatch
Thu, 01/17/19 - 09:36 am
Tags:
Apple, JNJ, Janssen, atrial fibrillation, Apple Watch, wearables, devices
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wed, 01/16/19 - 10:03 am
Tags:
Janssen, JNJ, Erleada, prostate cancer, Europe
Wed, 01/16/19 - 09:52 am
Tags:
Janssen, JNJ, Erleada, prostate cancer
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
Tags:
clinical trials, Multiple Myeloma, adaptive trial design, AbbVie, Celgene, Eli Lilly, Genentech, Janssen, Takeda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.